Edwards Lifesciences Corporation (BMV:EW)
Mexico
· Delayed Price · Currency is MXN 1,433.50
0.00 (0.00%)
At close: Jun 20, 2025, 2:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Transcatheter Aortic Valve Replacement | 4.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Transcatheter Aortic Valve Replacement Growth | 5.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Structural Heart | 999.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Structural Heart Growth | 1.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Critical Care | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Critical Care Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Transcatheter Mitral and Tricuspid Therapies | 394.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Transcatheter Mitral and Tricuspid Therapies Growth | 72.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| United States | 3.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 8.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 1.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 10.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 336.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | -3.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World | 588.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Growth | 8.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|